Outcome of Board Meeting held on 30th May, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Shri Dinesh Mills Ltd met on May 30, 2025 and approved the audited annual financial statements (standalone and consolidated) for FY 2024-25, subject to shareholder approval. The statutory auditor, R K Doshi & Co LLP, issued an unmodified (clean) opinion on the financial results. The Board also recommended a final dividend of Rs. 21 per equity share on a face value of Rs. 10 (i.e., 210%), pending shareholder approval. The consolidated results cover three subsidiaries (Dinesh Remedies Ltd, Stellent Chemicals Industries Ltd, Fernway Technologies Ltd) and one associate (McGean India Chemicals Pvt Ltd). Dinesh Remedies Ltd's results have been classified as discontinued operations following the board's October 2024 decision (approved by shareholders via postal ballot in December 2024) to sell/transfer the subsidiary.
A clean audit opinion and a robust 210% final dividend signal healthy financial performance and shareholder-friendly capital allocation, likely to be viewed positively by investors. The ongoing divestment of Dinesh Remedies Ltd may streamline the group's focus on its core textile business.